Stroke
Conditions
Interventions
Control group:Conventional treatment + mirror therapy
Experimental group:Conventional treatment + mirror therapy + nerve trunk stimulation acupuncture
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Refer to the diagnostic criteria for cerebral hemorrhage and cerebral infarction in *Diagnostic Points for Various Major Cerebrovascular Diseases in China 2019* compiled by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association, among which: Cerebral hemorrhage: (1) Sudden focal neurological deficit or headache, vomiting, and varying degrees of disturbance of consciousness. (2) Cranial CT/MRI shows intracerebral hemorrhage lesions. (3) Secondary or traumatic cerebral hemorrhage caused by other etiologies is excluded. Cerebral infarction: (1) Acute onset of focal neurological deficit, rarely global neurological deficit. (2) Cranial CT/MRI confirms the corresponding cerebral infarction focus, or symptoms and signs persist for more than 24 hours, or cause death within 24 hours. (3) Non-ischemic etiologies are excluded. 2) Meet the above diagnostic criteria for stroke and be confirmed by CT or MRI; 3) Have motor dysfunction of one upper limb, with the upper limb and hand in Brunnstrom stage II-V; 4) Modified Ashworth grade of muscle tone of the affected upper limb =1+; 5) First onset, age =18 years, course of disease =6 months; 6) Stable vital signs and able to actively cooperate with the assessment and treatment process; 7) Sufficient cognitive and language abilities to understand tasks and be able to focus for at least 10 minutes during mirror therapy; 8) Sitting balance = grade I and able to maintain it for more than 30 minutes; 9) Complete vision, able to process visual information, without hemianopia or ophthalmic diseases; 10) Voluntarily participate in this trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) The condition is in the acute or progressive stage, or is complicated by severe heart, liver, kidney diseases or infections; 2) Having severe cognitive impairment, mental disorders, or being uncooperative; 3) Having auditory comprehension disorders, visual impairments, or visuospatial disorders; 4) Complicated by muscle, bone and other diseases that affect the movement of the affected upper limb;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Upper Extremity Fugl-Meyer Assessment Scale for Motor Function;functional near-infrared spectroscopy,fNIRS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Wolf Motor Function Assessment Scale;Modified Barthel Index; | — |
Countries
CHINA
Contacts
Public ContactWANG QIUCHUN
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed